ShopVision | $4,100,000 | (Sep 19, 2025)
Hydrostor | $55,000,000 | (Sep 19, 2025)
Samara(US) | $34,000,000 | (Sep 19, 2025)
Certified by Founder
Lodge
Dispatch Bio
start up
- 24/07/2025
- Series A
- Undisclosed Amount
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
- Industry Biotechnology Research
- Website https://dispatchbio.com/
- LinkedIn https://www.linkedin.com/company/dispatch-bio/
Sevaro | $39,000,000 | (Sep 19, 2025)
Centari | $14,000,000 | (Sep 19, 2025)
Terra Oleo | $3,100,000 | (Sep 19, 2025)
Phia | $8,000,000 | (Sep 19, 2025)
Vibranium Labs | $4,600,000 | (Sep 19, 2025)
Invisible Technologies | $100,000,000 | (Sep 18, 2025)
Stablecore | $20,000,000 | (Sep 18, 2025)
Markup AI | $27,500,000 | (Sep 18, 2025)
Moby | $5,000,000 | (Sep 18, 2025)